Showing results (211-220 of 433) with videos related to
Sort By:
Pageof 44
European Heart Journal|May 6, 2005
Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trialPierre Théroux, Paul W Armstrong, Kenneth W Mahaffey, et al.Trials|June 21, 2013
Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapyRenato D Lopes, Yuliya Lokhnygina, Victor Hasselblad, et al.JACC. Cardiovascular Interventions|April 10, 2024
Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular DysfunctionMichael Mayer, Tess Allan, Kenneth L Harkin, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Interventional Cardiac Procedures and PregnancyKi Park, Anna E Bortnick, Kathryn J Lindley, et al.Journal of Vascular Surgery|October 3, 2024
Dynamic perioperative platelet activity and cardiovascular events in peripheral artery diseaseNatalie N Kennedy, Yuhe Xia, Tessa Barrett, et al.American Heart Journal|November 5, 2003
Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trialJohn K French, Henry A Feldman, Susan F Assmann, et al.The American Journal of Cardiology|January 29, 2013
Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT])Venu Menon, Witold Ruzyllo, Antonio C Carvalho, et al.Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.Circulation|August 20, 2003
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trialChristopher B Granger, Kenneth W Mahaffey, W Douglas Weaver, et al.Circulation|October 31, 2007
Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarctionStephen J Nicholls, Zeneng Wang, Robert Koeth, et al.Pageof 44